Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States

Original research
by
Levin, Adam et al

Release Date

2022

Geography

USA

Language of Resource

English

Full Text Available

No

Open Access / OK to Reproduce

No

Peer Reviewed

Yes

Objective

We examined whether American psychiatrists’ perceptions of four psychoactive drugs differed from those indicated by their schedules.

Findings/Key points

Mean ratings of safety and abuse/therapeutic potential of alprazolam and methamphetamine were equivalent to that of alcohol, and all three were rated more harmful than psilocybin and ketamine. American psychiatrists’ perceptions about safety and abuse/therapeutic potentials associated with certain psychoactive drugs were inconsistent with those indicated by their placement in drug schedules. These findings add to a growing consensus amongst experts that the current drug policy is not scientifically coherent.

Design/methods

Convenience sample of psychiatrists in the United States (N=181; Mean age=48.7; Female=35%).

Keywords

Policy/Regulatory
About prescribers
Stimulants
Hallucinogens/psychedelics